OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,523 | -22.3% | 13,157 | -33.7% | 0.00% | – |
| Q2 2023 | $65,059 | -77.5% | 19,835 | -72.4% | 0.00% | – |
| Q1 2021 | $289,000 | +74.1% | 71,956 | 0.0% | 0.00% | – |
| Q4 2020 | $166,000 | -55.4% | 71,956 | +11.1% | 0.00% | -100.0% |
| Q3 2020 | $372,000 | -21.8% | 64,757 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $476,000 | +1222.2% | 64,550 | +220.2% | 0.00% | – |
| Q1 2019 | $36,000 | -26.5% | 20,162 | 0.0% | 0.00% | – |
| Q4 2018 | $49,000 | -57.0% | 20,162 | 0.0% | 0.00% | – |
| Q3 2018 | $114,000 | -27.4% | 20,162 | 0.0% | 0.00% | – |
| Q2 2018 | $157,000 | +18.9% | 20,162 | +8.0% | 0.00% | – |
| Q1 2018 | $132,000 | +50.0% | 18,676 | +109.8% | 0.00% | – |
| Q4 2017 | $88,000 | +15.8% | 8,900 | 0.0% | 0.00% | – |
| Q3 2017 | $76,000 | -18.3% | 8,900 | 0.0% | 0.00% | – |
| Q2 2017 | $93,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |